Objectives: To measure the association between asthma drugs and death
or ICU admission due to asthma (severe life-threating attack of asthma
[SLTA]), and to assess the possibility that these associations may no
t be causal but due to the prescription of these drugs to patients wit
h more severe disease (confounding), Design: Retrospective cohort stud
y of 655 asthmatics who attended an emergency department in 1986 to 19
87 followed till death or May 1989. Methods: Outcome events were death
or ICU admission due to asthma (SLTA), All hospital attendances were
identified and patients classified at each according to drug exposure
and a wide variety of measures of asthma severity. Incidence rates wer
e computed as total outcome events divided by person-time contributed
for each subject classified according to drug use and asthma severity.
Rate ratio (RR) estimates for severe asthma outcomes associated with
use as compound to nonuse of asthma drugs were calculated, Severity ma
rkers were identified and used to adjust the crude RR estimates, Resul
ts: One hundred five SLTAs (15 deaths, 90 ICU admissions) occurred in
66 patients, Like inhaled fenoterol, oral beta-agonists, theophylline,
cromolyn, inhaled steroids, and oral steroids were all associated wit
h an increased risk of SLTA. When adjusted progressively for measures
of severity, these increased risks became insignificant except for cro
molyn. Conclusion: Unadjusted RR estimates for severe asthma events co
mparing exposure to a particular drug with nonuse are overestimates du
e to confounding. Control with two severity markers (hospital admissio
n in the last year, use of oral corticosteroid at the time of previous
admission) removes some confounding but control for additional severi
ty markers not available in previous studies reduces the effect estima
tes further, These results suggest that the problem of confounding is
substantial in nonrandomized epidemiologic studies of asthma drugs, Pr
evious studies reporting RR estimates are likely to be confounded.